Please login to the form below
Takecab
This page shows the latest Takecab news and features for those working in and with pharma, biotech and healthcare.
Biologics set to revolutionise the gastrointestinal market
Also contributing to the predicted market growth are recent product approvals such as Takeda's Takecab (vonoprazan) for gastroesophageal reflux disease, and Entvio (vedolizumab) for IBD.
Latest news
-
Rare disease therapies head the ‘class of 2015’
Baxalta. USA. vonoprazan fumarate. Takecab. acid-related diseases. potassium-competitive acid blocker. Takeda/Otsuka.
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Featured jobs
- Business Unit Head, Medical Communications, London
-
Excellent package
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
Subscribe to our email news alerts
- Brexit rebels win vote on European Medicines Agency alignment
- AstraZeneca joins Merck in Brexit stockpiling effort
- NHS England to Vertex: come clean on Orkambi offer
- Moving annual total (MAT)
- Vyriad inks immunotherapy alliance with Merck/Pfizer
- J&J’s Invokana aces diabetic kidney disease trial, setting up filings
- Love Island ads fuel body image problems, warn health leaders
- Daily Brief: Janssen's HIV vaccine, Q3 results, Biogen's Alzheimer's data
- Shining brighter than ever
- China’s BeiGene takes PD-1 antibody into pivotal trials
- Sangamo bulks up in cell therapy with TxCell acquisition
- Random42 win Creativity International Award for Scientific Animation
PMHub
COUCH.
WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
